Colorectal Liver Metastases
Cross-source consensus on Colorectal Liver Metastases from 1 sources and 5 claims.
1 sources · 5 claims
Uses
How it works
Comparisons
Background
Evidence quality
Highlighted claims
- Liver metastasis occurs in more than half of patients with colorectal cancer and is the leading cause of death from the disease. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- Liver resection remains the only curative treatment for colorectal cancer liver metastases. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- Fewer than 25% of patients with CRLM are considered resectable at diagnosis. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- Five-year overall survival is approximately 12% in unresectable CRLM compared with 41% among surgically treated patients. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- Common reasons for CRLM unresectability include insufficient future liver remnant, bilobar disease, and tumour proximity to vital structures. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review